Literature DB >> 30481561

Parvovirus B19 in Dilated Cardiomyopathy: There Is More Than Meets the Eye.

Job A J Verdonschot1, Leslie T Cooper2, Stephane R B Heymans3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30481561     DOI： 10.1016/j.cardfail.2018.11.017

Source DB:  PubMed          Journal:  J Card Fail        ISSN： 1071-9164            Impact factor:   5.712


× No keyword cloud information.
  3 in total

1.  Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients.

Authors:  Heinz-Peter Schultheiss; Thomas Bock; Heiko Pietsch; Ganna Aleshcheva; Christian Baumeier; Friedrich Fruhwald; Felicitas Escher
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

2.  Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double-blind, randomized, placebo-controlled clinical trial.

Authors:  Mark R Hazebroek; Michiel T H M Henkens; Anne G Raafs; Job A J Verdonschot; Jort J Merken; Robert M Dennert; Casper Eurlings; Myrurgia A Abdul Hamid; Petra F G Wolffs; Bjorn Winkens; Hans-Peter Brunner-La Rocca; Christian Knackstedt; Pieter van Paassen; Vanessa P M van Empel; Stephane R B Heymans
Journal:  Eur J Heart Fail       Date:  2021-01-07       Impact factor: 15.534

3.  Transcriptional Active Parvovirus B19 Infection Predicts Adverse Long-Term Outcome in Patients with Non-Ischemic Cardiomyopathy.

Authors:  Felicitas Escher; Ganna Aleshcheva; Heiko Pietsch; Christian Baumeier; Ulrich M Gross; Benedikt Norbert Schrage; Dirk Westermann; Claus-Thomas Bock; Heinz-Peter Schultheiss
Journal:  Biomedicines       Date:  2021-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.